What is the role of cardiac glycosides for the treatment of pulmonary arterial hypertension (PAH)?

Updated: Apr 25, 2018
  • Author: Kristin E Schwab, MD; Chief Editor: Zab Mosenifar, MD, FACP, FCCP  more...
  • Print

Cardiac glycosides are used for prevention and treatment of supraventricular arrhythmias associated with PAH and for patients who have concomitant left-sided heart failure. Digoxin is not useful in the treatment of right-sided ventricular failure.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!